What is Beam Therapeutics's investment proceeds?

Beam Therapeutics (BEAM) reported investment proceeds of $181.29M in Q1 2026.

How has Beam Therapeutics's investment proceeds changed year-over-year?

Beam Therapeutics's investment proceeds decreased by 16.5% year-over-year, from $217.15M to $181.29M.

What is the long-term trend for Beam Therapeutics's investment proceeds?

Over 3 years (2021 to 2024), Beam Therapeutics's investment proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $529.27M to $0.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

Beam Therapeutics BEAM Investment Proceeds

Investment Proceeds at other companies

Arrowhead ResearchARWR

$115.34M-2.4%

CRISPR TherapeuticsCRSP

$175.5K—

PTC TherapeuticsPTCT

$376.36M+175%

BridgeBio PharmaBBIO

$10M—

Protagonist TherapeuticsPTGX

$156.69M+38.4%

BiogenBIIB

$500K—

Other financials

Income statement

See full

Revenue$31.7M+325%

Operating income-$107.2M+10.1%

Net income-$94.3M+12.9%

EPS (diluted)-$0.91+26.0%

Balance sheet

See full

Cash & equivalents$288.3M-45.4%

Total debt$250.8M+58.6%

Total equity$1.2B+3.1%

Total assets$1.5B+0.9%

Cash flow

See full

Operating cash flow-$128.5M-23.7%

CapEx$2.2M-27.2%

Free cash flow-$130.7M-22.2%

Valuation

See full

Market cap$3.42B+24.5%

Profitability

See full

Operating margin-226.6%-90.5pp

Net margin-742.7%—

FCF margin-234%-86.6pp

Returns & leverage

See full

Return on equity-47.1%—

Debt / equity0.2×+0.1×

Current ratio17×+8.2×

Where this comes from

Reported directly by Beam Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.

The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beam Therapeutics's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Beam Therapeutics's investment proceeds?: Beam Therapeutics (BEAM) reported investment proceeds of $181.29M in Q1 2026.
How has Beam Therapeutics's investment proceeds changed year-over-year?: Beam Therapeutics's investment proceeds decreased by 16.5% year-over-year, from $217.15M to $181.29M.
What is the long-term trend for Beam Therapeutics's investment proceeds?: Over 3 years (2021 to 2024), Beam Therapeutics's investment proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $529.27M to $0.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.